Gabriele Ricci insider trades: Takeda Pharmaceutical (TAK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gabriele reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TAK | ↓ Sell | 25,088 | $17.10 | $429K | Direct | Aug 12, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TAK insiders
Open-market trades in the last 12 months
About Gabriele Ricci's insider trades
Gabriele Ricci is Chief Data & Tech. Officer at Takeda Pharmaceutical (TAK). Since Aug 10, 2026, Gabriele has reported no open-market purchases and 1 sale worth $429K on SEC Form 4. In the last 12 months: 1 sale ($429K).
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TAK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.